A human TRIM5α B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus

被引:55
作者
Diaz-Griffero, Felipe [1 ]
Perron, Michel [1 ]
McGee-Estrada, Kathleen [1 ]
Hanna, Robert [1 ]
Maillard, Pierre V. [2 ]
Trono, Didier [2 ]
Sodroski, Joseph [1 ,3 ]
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS,Dept Pathol,Div AIDS, Boston, MA 02115 USA
[2] Ecole Polytech Fed Lausanne, Global Hlth Inst, Sch Life Sci, Frontiers Genet Natl Ctr Competence Res, CH-1015 Lausanne, Switzerland
[3] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
基金
美国国家卫生研究院; 瑞士国家科学基金会;
关键词
retrovirus; restriction factor; uncoating; tripartite motif; mechanism; capsid; reverse transcription;
D O I
10.1016/j.virol.2008.05.008
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human TRIM5 alpha restricts N-tropic murine leukemia virus (N-MLV) but not B-tropic MLV (B-MLV) infection. Here we study B30.2/SPRY domain mutants of human TRIM5 alpha that acquire the ability to inhibit B-MLV infection prior to reverse transcription Without losing the ability to restrict N-MLV infection. Remarkably, these Mutants gain the ability to decrease the amount of particulate B-MIV capsids in the cytosol of infected cells. In addition, these mutants gain the ability to restrict SIVmac and HIV-2 infection. B-MLV and SIVmac infections were blocked by the mutant TRIM5 alpha proteins prior to reverse transcription. Thus, the range of retroviruses restricted by human TRIM5a can be increased by changes in the B30.2/SPRY domain, which also result in the ability to cause premature uncoating of the restricted retroviral capsid. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:233 / 242
页数:10
相关论文
共 32 条
[1]   Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins [J].
Anderson, Jenny L. ;
Campbell, Edward M. ;
Wu, Xiaolu ;
Vandegraaff, Nick ;
Engelman, Alan ;
Hope, Thomas J. .
JOURNAL OF VIROLOGY, 2006, 80 (19) :9754-9760
[2]   Construction and molecular analysis of gene transfer systems derived from bovine immunodeficiency virus [J].
Berkowitz, R ;
Ilves, H ;
Lin, WY ;
Eckert, K ;
Coward, A ;
Tamaki, S ;
Veres, G ;
Plavec, I .
JOURNAL OF VIROLOGY, 2001, 75 (07) :3371-3382
[3]   Use of a transient assay for studying the genetic determinants of Fv1 restriction [J].
Bock, M ;
Bishop, KN ;
Towers, G ;
Stoye, JP .
JOURNAL OF VIROLOGY, 2000, 74 (16) :7422-7430
[4]   Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism [J].
Cowan, S ;
Hatziioannou, T ;
Cunningham, T ;
Muesing, MA ;
Gottlinger, HG ;
Bieniasz, PD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11914-11919
[5]   Endocytosis is a critical step in entry of subgroup B avian leukosis viruses [J].
Diaz-Griffero, F ;
Hoschander, SA ;
Brojatsch, J .
JOURNAL OF VIROLOGY, 2002, 76 (24) :12866-12876
[6]   Comparative requirements for the restriction of retrovirus infection by TRIM5α and TRIMCyp [J].
Diaz-Griffero, Felipe ;
Kar, Alak ;
Lee, Mark ;
Stremlau, Matthew ;
Poeschla, Eric ;
Sodroski, Josedh .
VIROLOGY, 2007, 369 (02) :400-410
[7]   Modulation of retroviral restriction and proteasorne inhibitor-resistant turnover by changes in the TRIM5α B-Box 2 domain [J].
Diaz-Griffero, Felipe ;
Kar, Alak ;
Perron, Michel ;
Xiang, Shi-Hua ;
Javanbakht, Hassan ;
Li, Xing ;
Sodroski, Joseph .
JOURNAL OF VIROLOGY, 2007, 81 (19) :10362-10378
[8]   Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1 [J].
Diaz-Griffero, Felipe ;
Vandegraaff, Nick ;
Li, Yuan ;
McGee-Estrada, Kathleen ;
Stremlau, Matthew ;
Welikala, Sohanya ;
Si, Zhihai ;
Engelman, Alan ;
Sodroski, Joseph .
VIROLOGY, 2006, 351 (02) :404-419
[9]   Evidence against a direct antiviral activity of the proteasome during the early steps of HIV-1 replication [J].
Dueck, Megan ;
Guatelli, John .
VIROLOGY, 2007, 361 (01) :1-8
[10]   Inhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virus [J].
Fredericksen, BL ;
Wei, BL ;
Yao, J ;
Luo, TC ;
Garcia, JV .
JOURNAL OF VIROLOGY, 2002, 76 (22) :11440-11446